High visceral fat-to-muscle ratio predicated a recurrent fistula after definitive surgery for a small intestinal fistula with diffuse extensive abdominal adhesions: a cohort study.


Journal

International journal of surgery (London, England)
ISSN: 1743-9159
Titre abrégé: Int J Surg
Pays: United States
ID NLM: 101228232

Informations de publication

Date de publication:
01 Nov 2023
Historique:
received: 12 02 2023
accepted: 23 07 2023
medline: 24 11 2023
pubmed: 20 8 2023
entrez: 20 8 2023
Statut: epublish

Résumé

In patients diagnosed with sarcopenia, the presence of chronic preoperative inflammation, assessed by the ratio of the visceral fat area (VFA) to the total abdominal muscle area index (TAMAI) (VFA/TAMAI), has been found to adversely affect wound healing. An elevated VFA/TAMAI may contribute to a higher incidence of postoperative recurrent fistulas (RFs) following definitive surgery (DS) for small intestinal fistulas accompanied by diffuse extensive abdominal adhesions. The objective of this study was to evaluate the predictive value of VFA/TAMAI for postoperative RFs. The study enrolled 183 sarcopenic patients, with a median age of 51 years [interquartile range (IQR): 38-61 years), a median body mass index of 19.6 kg/m 2 (IQR: 18.9-21.0 kg/m 2 ) who underwent DS for small intestinal fistulas between January 2018 and October 2022 were included in the multicenter study. The outcomes assessed were RFs and postoperative length of stay (LOS). VFA/TAMAI was examined as a potential risk factor for each outcome. Out of the 183 patients, 20.2% ( n =37) developed RFs. The multivariate regression analysis identified VFA/TAMAI as the sole factor associated with RFs [odds ratio=1.78, 95% confidence interval (CI): 1.09-2.87, P =0.02]. The multivariable Cox regression analysis demonstrated that an elevated VFA/TAMAI was linked to a reduced postoperative LOS (hazard ratio=0.69, 95% CI: 0.59-0.81, P <0.001). In sarcopenic patients, a high VFA/TAMAI predicated the occurrence of RFs after DS for small intestinal fistulas in the presence of diffuse extensive abdominal adhesions.

Sections du résumé

BACKGROUND BACKGROUND
In patients diagnosed with sarcopenia, the presence of chronic preoperative inflammation, assessed by the ratio of the visceral fat area (VFA) to the total abdominal muscle area index (TAMAI) (VFA/TAMAI), has been found to adversely affect wound healing. An elevated VFA/TAMAI may contribute to a higher incidence of postoperative recurrent fistulas (RFs) following definitive surgery (DS) for small intestinal fistulas accompanied by diffuse extensive abdominal adhesions. The objective of this study was to evaluate the predictive value of VFA/TAMAI for postoperative RFs.
METHODS METHODS
The study enrolled 183 sarcopenic patients, with a median age of 51 years [interquartile range (IQR): 38-61 years), a median body mass index of 19.6 kg/m 2 (IQR: 18.9-21.0 kg/m 2 ) who underwent DS for small intestinal fistulas between January 2018 and October 2022 were included in the multicenter study. The outcomes assessed were RFs and postoperative length of stay (LOS). VFA/TAMAI was examined as a potential risk factor for each outcome.
RESULTS RESULTS
Out of the 183 patients, 20.2% ( n =37) developed RFs. The multivariate regression analysis identified VFA/TAMAI as the sole factor associated with RFs [odds ratio=1.78, 95% confidence interval (CI): 1.09-2.87, P =0.02]. The multivariable Cox regression analysis demonstrated that an elevated VFA/TAMAI was linked to a reduced postoperative LOS (hazard ratio=0.69, 95% CI: 0.59-0.81, P <0.001).
CONCLUSION CONCLUSIONS
In sarcopenic patients, a high VFA/TAMAI predicated the occurrence of RFs after DS for small intestinal fistulas in the presence of diffuse extensive abdominal adhesions.

Identifiants

pubmed: 37598405
doi: 10.1097/JS9.0000000000000647
pii: 01279778-990000000-00568
pmc: PMC10651287
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3490-3496

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

Références

Capobianco A, Cottone L, Monno A, et al. The peritoneum: healing, immunity, and diseases. J Pathol 2017;243:137–147.
van Baal JO, Van de Vijver KK, Nieuwland R, et al. The histophysiology and pathophysiology of the peritoneum. Tissue Cell 2017;49:95–105.
Hellebrekers BW, Kooistra T. Pathogenesis of postoperative adhesion formation. Br J Surg 2011;98:1503–1516.
Moris D, Chakedis J, Rahnemai-Azar AA, et al. Postoperative abdominal adhesions: clinical significance and advances in prevention and management. J Gastrointest Surg 2017;21:1713–1722.
Ince A, Eroglu A, Tarhan O, et al. Peritoneal fibrinolytic activity in peritonitis. Am J Surg 2002;183:67–69.
Zhao R, Liang H, Clarke E, et al. Inflammation in chronic wounds. Int J Mol Sci 2016;17:2085.
Nagaraja S, Wallqvist A, Reifman J, et al. Computational approach to characterize causative factors and molecular indicators of chronic wound inflammation. J Immunol 2014;192:1824–1834.
Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985) 2007;102:919–925.
Tian W, Zhao R, Xu X, et al. Chyme reinfusion reducing the postoperative complications after definitive surgery for small intestinal enteroatmospheric fistula: a cohort study. Front Nutr 2022;9:708534.
Tian W, Yan M, Xu X, et al. Risk factors and outcomes for postoperative ileus after small intestinal fistula excision in patients with diffuse extensive abdominal adhesions. Front Surg 2021;8:632241.
Cruz-Jentoft AJ, Sayer AA. Sarcopenia [published correction appears in Lancet. 2019;393(10191):2590]. Lancet 2019;393:2636–2646.
Feliciano EMC, Kroenke CH, Meyerhardt JA, et al. Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol 2017;3:e172319.
Mathew G, Agha R. for the STROCSS Group. STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case–control studies in Surgery. Int J Surg 2021;96:106165.
Hobson KG, DeWing M, Ho HS, et al. Expression of transforming growth factor beta1 in patients with and without previous abdominal surgery. Arch Surg 2003;138:1249–1252.
Nishida Y, Kato Y, Kudo M, et al. Preoperative sarcopenia strongly influences the risk of postoperative pancreatic fistula formation after pancreaticoduodenectomy. J Gastrointest Surg 2016;20:1586–1594.
Visschers RG, Olde Damink SW, Winkens B, et al. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg 2008;32:445–453.
Jang M, Park HW, Huh J, et al. Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI. Eur Radiol 2019;29:2417–2425.
Pecorelli N, Carrara G, De Cobelli F, et al. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg 2016;103:434–442.
Ratnayake CBB, Wells C, Olsson M, et al. Sarcopenic obesity and post-operative morbidity after pancreatic surgery: a cohort study. ANZ J Surg 2019;89:1587–1592.
Zhang WT, Lin J, Chen WS, et al. Sarcopenic obesity is associated with severe postoperative complications in gastric cancer patients undergoing gastrectomy: a prospective study. J Gastrointest Surg 2018;22:1861–1869.
Morozzi G, Beccafico S, Bianchi R, et al. Oxidative stress-induced S100B accumulation converts myoblasts into brown adipocytes via an NF-κB/YY1/miR-133 axis and NF-κB/YY1/BMP-7 axis. Cell Death Differ 2017;24:2077–2088.
Munireddy S, Kavalukas SL, Barbul A. Intra-abdominal healing: gastrointestinal tract and adhesions. Surg Clin North Am 2010;90:1227–1236.
Boelens PG, Heesakkers FF, Luyer MD, et al. Reduction of postoperative ileus by early enteral nutrition in patients undergoing major rectal surgery: prospective, randomized, controlled trial. Ann Surg 2014;259:649–655.
Tian W, Xu X, Yao Z, et al. Early enteral nutrition could reduce risk of recurrent leakage after definitive resection of anastomotic leakage after colorectal cancer surgery. World J Surg 2021;45:320–330.

Auteurs

Weiliang Tian (W)

Research Institute of General Surgery, Jinling Hospital, Nanjing Medical University.

Xin Xu (X)

Department of General Surgery, Jiangning Hospital, Nanjing, Jiangsu.

Risheng Zhao (R)

Department of General Surgery, Jiangning Hospital, Nanjing, Jiangsu.

Tao Tian (T)

Department of General Surgery, Shanghai 9 Hospital, Shanghai.

Wuhan Li (W)

Department of General Surgery, Anhui Provincial Hospital, Hefei, Anhui, People's Republic of China.

Ming Huang (M)

Department of General Surgery, Jiangning Hospital, Nanjing, Jiangsu.

Yunzhao Zhao (Y)

Department of General Surgery, Jiangning Hospital, Nanjing, Jiangsu.

Zheng Yao (Z)

Department of General Surgery, Jiangning Hospital, Nanjing, Jiangsu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH